Filings monitor · HUM

What HUMANA INC's SEC filings said

10-Q for 2026Q3, filed 6 Nov 2026, and 2 8-Ks since. Each line is something a filing stated, ranked by score and linked to its source.

Ranked highest

1. Guidance / Outlook82 · importance in its document · 8-K exhibit · 6 Nov 2026
   Humana raised FY 2026 adjusted EPS guidance to at least $9.50 from at least $9.00. GAAP EPS guidance increased to at least $15.09 from at least $6.52. The company said adjusted guidance anticipates a year-over-year decline due to the Star…
2. Capital Adequacy and Requirements81 · importance in its document · 10-Q · 2026Q3
   As of June 30, 2026, Humana’s state-regulated subsidiaries had approximately $15.7 billion of aggregate statutory capital and surplus, exceeding aggregate minimum regulatory requirements of $8.9 billion. The subsidiaries paid…
3. Regulatory Capital and Dividends75 · importance in its document · 10-Q · 2026Q3
   State-regulated subsidiaries face state-level restrictions on dividends, loans, and other transfers to Humana Inc., including prior approval requirements for certain extraordinary dividends. As of June 30, 2026, these subsidiaries had…
4. Medical Cost Trends71 · importance in its document · 10-Q · 2026Q3
   Consolidated benefits expense increased 29.8% to $36.3 billion in the 2026 quarter and 28.4% to $105.4 billion in the first nine months. The consolidated benefit ratio rose 280 basis points to 93.9% in the quarter and 220 basis points to…
5. Membership / Enrollment Trends69 · importance in its document · 10-Q · 2026Q3
   At September 30, 2026, individual Medicare Advantage membership was 6.46 million, up 23.3% year over year, including 958,300 D-SNP members, a 25.1% increase. Group Medicare Advantage membership grew 27.8% to 728,300, while stand-alone PDP…

Ranked by score, 0–100. A topic read from a document carries its importance within that document; an 8-K event carries the rule score that ranks a filing among filings. Neither is about the share price, and the two scales are named on each row because they are not the same measure.

Latest report: 10-Q · 2026Q3 filed 6 Nov 2026

Full report · Filing on EDGAR

• Capital Adequacy and RequirementsImportance 81
  As of June 30, 2026, Humana’s state-regulated subsidiaries had approximately $15.7 billion of aggregate statutory capital and surplus, exceeding aggregate minimum regulatory requirements of $8.9 billion. The…
• Regulatory Capital and DividendsImportance 75
  State-regulated subsidiaries face state-level restrictions on dividends, loans, and other transfers to Humana Inc., including prior approval requirements for certain extraordinary dividends. As of June 30, 2026, these…
• Medical Cost TrendsImportance 71
  Consolidated benefits expense increased 29.8% to $36.3 billion in the 2026 quarter and 28.4% to $105.4 billion in the first nine months. The consolidated benefit ratio rose 280 basis points to 93.9% in the quarter and…
• Membership / Enrollment TrendsImportance 69
  At September 30, 2026, individual Medicare Advantage membership was 6.46 million, up 23.3% year over year, including 958,300 D-SNP members, a 25.1% increase. Group Medicare Advantage membership grew 27.8% to 728,300,…
• Primary Care Joint VentureImportance 65
  In October 2026, Humana entered a joint venture agreement with funds and accounts managed by HPS Investment Partners, part of BlackRock, to operate its primary-care strategic partnership, replacing the CenterWell and…
• Cash Flow and LiquidityImportance 63
  Cash and cash equivalents increased to approximately $6.9 billion at September 30, 2026, from $4.2 billion at December 31, 2025. Operating cash flow rose to $5.4 billion in the first nine months of 2026 from $2.6…
• Interest Expense TrendsImportance 61 · +1 more on this subject
  Interest expense increased 29.2% to $217 million in the third quarter of 2026 and 25.2% to $607 million in the first nine months. The increases were primarily driven by financing costs, including 2026 liquidity and…
• Revenue Performance and MixImportance 59
  Total revenue increased 26.1% to $41.2 billion in the third quarter of 2026 and 25.2% to $121.7 billion in the first nine months, compared with the corresponding 2025 periods. Insurance premiums rose 26.0% in the…
• CenterWell Payor-Agnostic GrowthImportance 52
  CenterWell external services revenue increased 40.4% in the quarter and 35.2% in the nine-month period, primarily reflecting expansion of its payor-agnostic client base. Growth was concentrated in primary care and…
• Restructuring ChargesImportance 48
  Humana recorded value-creation and transformation charges of $179 million in the first nine months of 2026, compared with $320 million in the first nine months of 2025, a 44% decrease. The charges were $25 million in…
• Income Tax Rate ChangesImportance 40
  The effective tax rate was 19.7% for the third quarter of 2026, compared with negative 77.3% in the 2025 quarter. For the first nine months, the effective rate rose to 24.8% from 20.1% in 2025. Humana attributed the…
• Medicare GLP-1 Bridge ProgramImportance 38
  Effective July 1, 2026, Humana began serving as central processor for a time-limited CMS demonstration giving eligible Medicare Part D beneficiaries access to certain GLP-1 medications for weight management outside the…

8-K filings last 12 months

• Press release attached to an 8-K9 Nov 2026 · 8-K
  Read from the attached exhibit: Debt Tender Offers
• Guidance raised6 Nov 2026 · 8-K Item 2.02 · Flagged · rule score 60
  “Raises Full Year 2026 Adjusted EPS Guidance”
  Read from the attached exhibit: Guidance / Outlook · Restructuring Charges · Strategic Initiatives
• Press release attached to an 8-K13 Oct 2026 · 8-K
  Read from the attached exhibit: Acquisitions and Partnerships · Balance Sheet and Liquidity · CenterWell Clinic Network Expansion
• Management change (filing not read)29 Jul 2026 · 8-K Item 5.02 · Routine · rule score 20
• Results (release not read)29 Jul 2026 · 8-K Item 2.02 · Routine · rule score 20
• New debt19 May 2026 · 8-K Items 1.01, 2.03 · Routine · rule score 25
• Results (release not read)29 Apr 2026 · 8-K Item 2.02 · Routine · rule score 20
• Management change (filing not read)10 Apr 2026 · 8-K Item 5.02 · Routine · rule score 20
• New debt9 Mar 2026 · 8-K Items 1.01, 2.03 · Routine · rule score 25
• Results (release not read)11 Feb 2026 · 8-K Item 2.02 · Routine · rule score 20
• Management change (filing not read)16 Dec 2025 · 8-K Item 5.02 · Routine · rule score 20

Topics are read from the text of the 10-K, 10-Q or the exhibit attached to an 8-K, each linked to the passage it came from. 8-K events are labelled by fixed rules from the item codes and the filing text — the same rules for every company and every year. The Full Picture merges these with earnings calls and news.